FDA 2017–19; AEI; the Pfizer board; the most public explainer of drug regulation of his generation
This is Jonathan Hare's account, with its provenance shown. The person or organization named has not yet claimed or corrected it.
FDA commissioner, 2017–19. In Jonathan Hare's account (S-192), he and Jack Lewin met numerous times with almost every FDA commissioner of the era, and Scott Gottlieb is on that list. This page is deliberately thin: it exists so the archive-miner pass over Hare's email can attach the dates, rooms and substance. Their account is invited meanwhile.
The public record, at web grade. A physician and AEI fellow who served as FDA commissioner from 2017 to 2019 — the generic-approvals acceleration and the youth-vaping fight are his signature — then a Pfizer director and the most visible public explainer of drug regulation and pandemic policy of his generation, including Uncontrolled Spread. In this record's network: he sits on the same FDA page as the Hamburg meeting and the Seyfert-Margolis pilot; the record's supply-chain claim — that the Trust Network can carry any supply chain, food or drug — is a claim his drug-shortage and compounding files would test on contact.
There is no single root. This is one view of the graph, from this node — what you see depends on where you enter and what you are looking for.
The physician-executive whose reach runs from Aetna's CEO to a $120m statewide transformation
Open →FDA commissioner, 2017–19Hamburg's meeting and the Seyfert-Margolis pilot; commissioners Califf, Gottlieb, Woodcock, McClellan; the division chiefs of CDER, CDRH and CBER
Open →Everything above is a distillation. The primary source is published in full, so that any claim on this page can be walked back to what was actually said — and where the two differ, the source governs.
This entry is deliberately incomplete. The gaps below are the things only certain people can settle — and settling one is a contribution like any other: recorded, timestamped and attributed to whoever made it.
Correct anything wrong, add what only you know, or claim this entry as your own. Write to evidence@qpncatalyst.io and Jonathan directly (both are on the button) — a timestamped confirmation comes back with your submission attached, as your own independent record. No account, no permission, no institutional standing required.
Public contributions earn Publicity Premium; bringing others who were there earns Cascade Premium. Everything is valued retrospectively as outcomes verify, so nothing has to be priced up front.
Correct this entry → Add a story, photo or link → Browse the graph →